Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Barlas

Showing results (31-40 of 149) with videos related to

Pageof 15
Sort By:
P & T : a Peer-Reviewed Journal for Formulary Management|March 28, 2014
Pharmacists, Deluged With Requirements, Pressure FDA to Standardize REMS ProgramsStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|March 28, 2014
New congressional bill attempts to aid pharmacy response to drug shortages: compounding and tracing provisions seek to improve quality of drug supplyStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|May 3, 2014
Major Changes for Part D Drug Plans Scheduled for 2015: Health Plans and PBMs Would Be the Chief BeneficiariesStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|November 10, 2018
Federal Safe Harbor for Value-Based Contracts Being Considered: P&T Committees Can Receive Data Beyond the Drug LabelStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|April 7, 2017
FDA Pleases No One With Final Guidance On Naming of Biologicals and BiosimilarsStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|March 3, 2017
FDA Revisits Rules on Drug and Device Communication: Will the Agency Relax Existing Industry-Opposed Restrictions?Stephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|January 17, 2017
2017 Presages Dramatic Change For Federal Health Care Policies: Republicans Are Likely to Face Hiccups Along the WayStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|June 3, 2014
FDA devotes new resources to upgrading generic drug safety: but in some instances, the industry is pushing backStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|January 7, 2014
New FDA medical device rule imposes minimal burden on hospitals: facilities able to scan unique device identifiers will benefitStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|February 13, 2015
HHS Proposes Formulary Changes For Marketplace Health Plans: P&T Committees Would Take On a More Visible RoleStephen Barlas
Pageof 15

Showing results (31-40 of 149) with videos related to

Sort By:
Pageof 15
P & T : a Peer-Reviewed Journal for Formulary Management|March 28, 2014
Pharmacists, Deluged With Requirements, Pressure FDA to Standardize REMS ProgramsStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|March 28, 2014
New congressional bill attempts to aid pharmacy response to drug shortages: compounding and tracing provisions seek to improve quality of drug supplyStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|May 3, 2014
Major Changes for Part D Drug Plans Scheduled for 2015: Health Plans and PBMs Would Be the Chief BeneficiariesStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|November 10, 2018
Federal Safe Harbor for Value-Based Contracts Being Considered: P&T Committees Can Receive Data Beyond the Drug LabelStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|April 7, 2017
FDA Pleases No One With Final Guidance On Naming of Biologicals and BiosimilarsStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|March 3, 2017
FDA Revisits Rules on Drug and Device Communication: Will the Agency Relax Existing Industry-Opposed Restrictions?Stephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|January 17, 2017
2017 Presages Dramatic Change For Federal Health Care Policies: Republicans Are Likely to Face Hiccups Along the WayStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|June 3, 2014
FDA devotes new resources to upgrading generic drug safety: but in some instances, the industry is pushing backStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|January 7, 2014
New FDA medical device rule imposes minimal burden on hospitals: facilities able to scan unique device identifiers will benefitStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|February 13, 2015
HHS Proposes Formulary Changes For Marketplace Health Plans: P&T Committees Would Take On a More Visible RoleStephen Barlas
Pageof 15